Do more with one link - claim and personalize your FREE link today! Effortlessly schedule, video meet, message chat, network, share materials, e-sign, etc – all in one spot. Collaborate, Nurture connections, Improve client services, Expedite deal closures, and more. 💼 Join FREE!!

Recent Comments

    acute myeloid leukemia tagged posts

    For Children, Young Adults with Recurrent AML, Immunotherapy Shows Promise

    December 15, 2021, Categories  Biology/Biotechnology, Health/Medical

    GARA ELIZABETH PHOTOGRAPHYResearchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that pre-activated natural killer cells can help some children and young adults with recurrent AML and few other treatment options. Pictured is Weston Robinett, 3, a patient who received this investigational therapy at Siteman Kids at St. Louis Children’s Hospital and Washington University School of Medicine. He remains in remission more than two years after treatment.

    Natural killer cells could help young patients with few treatment options. An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return...

    Read More

    Protein ‘Handbrake’ halts Leukemia in its Tracks

    January 19, 2016, Categories  Biology/Biotechnology, Health/Medical

    Researchers from the Walter and Eliza Hall Institute in Melbourne, Australia, have shown they can stop leukemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth. The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukemia. Credit: Walter and Eliza Hall Institute

    Researchers from the Walter and Eliza Hall Institute in Melbourne, Australia, have shown they can stop leukemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth. The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukemia. Credit: Walter and Eliza Hall Institute

    Melbourne researchers have showed that they can stop leukemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.They discovered targeting protein Hhex could cure acute myeloid leukemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukemia...

    Read More